Selective uptake of boronophenylalanine by glioma stem/progenitor cells

Document Type

Article

Publication Date

8-1-2012

Abstract

The success of boron neutron capture therapy (BNCT) depends on the amount of boron in cells and the tumor/blood and tumor/(normal tissue) boron concentration ratios. For the first time, measurements of boron uptake in both stem/progenitor and differentiated glioma cells were performed along with measurements of boron biodistribution in suitable animal models. In glioma stem/progenitor cells, the selective accumulation of boronophenylalanine (BPA) was lower, and retention of boron after BPA removal was longer than in differentiated glioma cells in vitro. However, boron biodistribution was not statistically significantly different in mice with xenografts. © 2012 Elsevier Ltd.

Publication Source (Journal or Book title)

Applied Radiation and Isotopes

First Page

1512

Last Page

1518

This document is currently not available here.

Share

COinS